|
|
| | NCS-382 sodium Basic information |
| Product Name: | NCS-382 sodium | | Synonyms: | NCS-382;NCS-382, SODIUM SALT;5,7,8,9-Tetrahydro-5-hydroxy-6H-benzocyclohepten-6-ylidene acetic acid hydrate monosodium salt;[(2,3,4,5-Tetrahydro-1-hydroxy-1H-benzocyclohepten)-4-ylidene]acetic acid;5,7,8,9-Tetrahydro-5-hydroxy-6H-benzocyclohepten-6-ylidene acetic acid monosodium salt hydrate;(5,7,8,9-TETRAHYDRO-5-HYDROXY-6H-BENZOCYCLOHEPTEN-6-YLIDENE)-MONOSODIUM SALT ACETIC ACID;6,7,8 9-TETRAHYDRO-5[H]-BENZOCYCLOHEPTENE-5-OL-4-YLIDENE ACETIC ACID SODIUM SALT;6,7,8,9-TETRAHYDRO-5-HYDROXY-5H-BENZOCYCLOHEPT-6-YLIDENEACETIC ACID | | CAS: | 131733-92-1 | | MF: | C13H14O3.Na | | MW: | 241.24 | | EINECS: | | | Product Categories: | All Inhibitors;Inhibitors | | Mol File: | 131733-92-1.mol |  |
| | NCS-382 sodium Chemical Properties |
| Melting point | 141-143°C | | RTECS | MA0600800 | | storage temp. | Desiccate at +4°C | | solubility | H2O: 22 mg/mL | | form | solid | | color | white or off-white |
| | NCS-382 sodium Usage And Synthesis |
| Chemical Properties | White Powder | | Uses | NCS-382 is an antagonist of γ-hydroxybutyric acid (GHB). | | Uses | Possesses antagonistic properties at -hydroxybutyrate (GHB) receptor cites. It antagonizes both the cGMP increase and inositol phosphate accumulation induced by GHB in the hippocampus and suppresses the GHB-induced modification of dopamine relea | | Biological Activity | γ -Hydroxybutyric acid antagonist, anticonvulsant. |
| | NCS-382 sodium Preparation Products And Raw materials |
|